Alcohol

Alcohol

SCHEMBL4867703

CCO.CCOC(=O)OCC

nearest known ligand 0.87

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Alcohol. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.87
SOAT1 P35610 1/20 0.67
LMNA P02545 1/20 0.53
HSD17B10 Q99714 1/20 0.53
ALOX15 P16050 1/20 0.50
MGAM O43451 1/20 0.50
GAA P10253 1/20 0.50
SI P14410 1/20 0.50
MGAM2 Q2M2H8 1/20 0.50
TRPA1 O75762 1/20 0.46
KDM4E B2RXH2 1/20 0.43
PKM P14618 1/20 0.43
TSHR P16473 3/20 0.40
HCAR2 Q8TDS4 1/20 0.40
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
GLO1 Q04760 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP4F2 P78329 1/20 0.38
CYP4A11 Q02928 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Alcohol SCHEMBL27831880 0.97 ALDH1A1 (0.81) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL1332089 0.93
SCHEMBL1958756 0.93 ALDH1A1 (1.00) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL3673 0.93
Bicarbonate SCHEMBL23051690 0.91 ALDH1A1 (0.72) ALDH1A1SOAT1LMNAHSD17B10ALOX15
Ethylene Glycol SCHEMBL1274144 0.90 ALDH1A1 (0.81) ALDH1A1SOAT1LMNAHSD17B10ALOX15
Charcoal, Activated SCHEMBL1901032 0.90
SCHEMBL544742 0.90
Water SCHEMBL22362219 0.90
Bromide SCHEMBL10459370 0.90

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114057579-A Method for preparing asymmetric carbonate by rectifying catalytic reaction of symmetric carbonate 河北工业大学 2022-02-18 CN disclosed
CN-113061087-A Method and device for producing methyl ethyl carbonate 河南红东方化工股份有限公司 2021-07-02 CN disclosed
US-10944119-B2 Methods and devices for storage and release of hydrogen YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) 2021-03-09 US disclosed
CN-106748782-B A kind of method of magnesium aluminium lanthanum composite oxide catalytic Catalysts of Preparing Methyl Ethyl Carbonate 邵阳学院 2019-11-08 CN disclosed
CN-106748781-B A kind of method that calcium and magnesium aluminium composite oxide catalyzes and synthesizes methyl ethyl carbonate 邵阳学院 2019-10-11 CN disclosed
CN-106588659-B A method of roasting state hydrocalumite catalyzes and synthesizes methyl ethyl carbonate 邵阳学院 2019-05-14 CN disclosed
CN-109180490-A The lithium electricity homogeneous production technology of high-purity diethyl carbonate 沈阳化工大学 2019-01-11 CN disclosed
CN-106748781-A A kind of method that calcium and magnesium aluminium composite oxide catalyzes and synthesizes methyl ethyl carbonate 邵阳学院 2017-05-31 CN disclosed
CN-106748782-A A kind of method of magnesium aluminium lanthanum composite oxide catalytic Catalysts of Preparing Methyl Ethyl Carbonate 邵阳学院 2017-05-31 CN disclosed
CN-106588659-A Method for synthesizing methyl ethyl carbonate under catalysis of roasted-state hydrocalumite 邵阳学院 2017-04-26 CN disclosed
CN-103214373-B Ethyl methyl carbonate synthesis method UNIV SHANDONG 2014-08-06 CN disclosed
CN-103214373-A Ethyl methyl carbonate synthesis method UNIV SHANDONG 2013-07-24 CN disclosed
EP-1789070-B1 TAJ IN NEURONAL FUNCTION BIOGEN IDEC INC (US) 2012-10-24 EP disclosed
CN-102212010-A Method for synthesizing methyl ethyl carbonate UNIV CHANGZHOU 2011-10-12 CN disclosed
US-7417156-B2 Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers JOHNS HOPKINS UNIVERSITY (US) 2008-08-26 US disclosed
US-20060142377-A1 Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high selectively, stability and efficacy and methods of making the same JOHNS HOPKINS UNIVERSITY-LICENSE & TECHNOLOGY DEVE (US) 2006-06-29 US disclosed
WO-2004028476-A2 ARTEMISININ-DERIVED TRIOXANE DIMERS JOHNS HOPKINS UNIVERSITY (US) 2004-04-08 WO disclosed
US-4749755-A BLENDED,COEXTRUDED WITH POLYCARBONATES BAYER AKTIENGESELLSCHAFT (DE) 1988-06-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060142377-A1 Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high selectively, stability and efficacy and methods of making the same HCCS, ACIN1, ADH1A ALDH1A1 175/4885SOAT1 902/4885LMNA 1777/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.